Co-Authors
This is a "connection" page, showing publications co-authored by Julian Schulze Zur Wiesch and Stefan Schmiedel.
Connection Strength
2.002
-
Sustained Response After Remdesivir and Convalescent Plasma Therapy in a B-Cell-Depleted Patient With Protracted Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021 12 06; 73(11):e4020-e4024.
Score: 0.246
-
Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19. iScience. 2021 Jul 23; 24(7):102752.
Score: 0.238
-
Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020. J Clin Med. 2021 May 24; 10(11).
Score: 0.237
-
Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza. Sci Rep. 2021 03 11; 11(1):5803.
Score: 0.233
-
Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73- Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes. Cells. 2020 07 22; 9(8).
Score: 0.223
-
Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients. Medicine (Baltimore). 2019 Aug; 98(32):e16721.
Score: 0.209
-
Epidemiology, clinical and laboratory features of 24 consecutive cases of leptospirosis at a German infectious disease center. Infection. 2018 Dec; 46(6):847-853.
Score: 0.194
-
CD32 Expression of Different Memory T Cell Subpopulations in the Blood and Lymph Nodal Tissue of HIV Patients and Healthy Controls Correlates With Immune Activation. J Acquir Immune Defic Syndr. 2018 04 01; 77(4):345-349.
Score: 0.190
-
SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies. Viruses. 2021 04 12; 13(4).
Score: 0.059
-
Malaria in the Time of COVID-19: Do Not Miss the Real Cause of Illness. Trop Med Infect Dis. 2021 Mar 26; 6(2).
Score: 0.059
-
Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study. Int J Hyg Environ Health. 2021 03; 232:113671.
Score: 0.057
-
Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020; 2(2):fcaa205.
Score: 0.057